Lee SW, Ha EK, Yeniova AO, Moon SY, Kim SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, Yoo IK, Yon DK. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 2021;70:30 de julio. [Ref.ID 103733]

Haller CA, Anderson IB, Kim SY, Blanc PD. An evaluation of selected herbal reference texts and comparison to published reports of adverse herbal events. Adverse Drug React Toxicol Rev 2002;21:143-50. [Ref.ID 62144]

Kim SY, Park HS, Sunwoo S, Byeon JJ, Song YM, Seo HG, Kim CH, Cheon KS, Yoo SM, Lee JK, and the Korea Post-Marketing Surveillance Research Group. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol Drug Saf 2001;9:603-9. [Ref.ID 55856]